Together we are beating cancer

Donate now

Lymphoma

Showing 12 out of 86 results
Senedd Cymru, or the Welsh Parliament.

Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change. Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change.

by Tim Gunn | News | 8 June 2023

8 June 2023

Lab equipment at our Experimental Cancer Medicine Centre in Southampton
  • Science & Technology
  • Health & Medicine

3 ways we're helping teenagers and young adults with cancer

Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them. Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them.

by Tim Gunn | In depth | 18 April 2023

18 April 2023

Fatimah, 19, near her home, and Adam, 23, on holiday. They were both diagnosed with cancer in their mid-teens.

For Teenage and Young Adult Cancer Awareness Month, we're hearing from four supporters who've faced the unique challenges of teenage cancer. For Teenage and Young Adult Cancer Awareness Month, we're hearing from four supporters who've faced the unique challenges of teenage cancer.

by Tom Bourton | Personal stories | 6 April 2023

6 April 2023

Lymphoma cells

Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England

by In collaboration with PA Media Group | News | 23 May 2022

23 May 2022

Lung cancer cells

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected. Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

by Harry Jenkins | News | 11 November 2021

11 November 2021

antibodies

How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma. How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma.

by Cancer Research UK | Research Feature | 2 July 2021

2 July 2021

3D rendering of blood cancer
  • Science & Technology
  • Health & Medicine

Scientists trial new way to boost CAR T-cell therapy

Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that ‘reboots’ a treatment for some people with blood cancer whose cancer starts to come back. Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that ‘reboots’ a treatment for some people with blood cancer whose cancer starts to come back.

by Harry Jenkins | News | 23 June 2021

23 June 2021

Doctor looking at brain scan

We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma. We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.

by Lilly Matson | Analysis | 27 January 2021

27 January 2021